Teachers Retirement System of The State of Kentucky Sells 40,083 Shares of Bristol-Myers Squibb (BMY)

Teachers Retirement System of The State of Kentucky reduced its holdings in shares of Bristol-Myers Squibb (NYSE:BMY) by 11.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 306,270 shares of the biopharmaceutical company’s stock after selling 40,083 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Bristol-Myers Squibb were worth $18,768,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Advisor Partners LLC lifted its stake in Bristol-Myers Squibb by 6.9% in the 3rd quarter. Advisor Partners LLC now owns 36,961 shares of the biopharmaceutical company’s stock worth $2,356,000 after purchasing an additional 2,382 shares in the last quarter. Van ECK Associates Corp lifted its stake in Bristol-Myers Squibb by 0.7% in the 3rd quarter. Van ECK Associates Corp now owns 791,275 shares of the biopharmaceutical company’s stock worth $50,436,000 after purchasing an additional 5,451 shares in the last quarter. Aperio Group LLC lifted its stake in Bristol-Myers Squibb by 12.7% in the 3rd quarter. Aperio Group LLC now owns 854,457 shares of the biopharmaceutical company’s stock worth $54,463,000 after purchasing an additional 96,561 shares in the last quarter. D.A. Davidson & CO. lifted its stake in Bristol-Myers Squibb by 8.6% in the 3rd quarter. D.A. Davidson & CO. now owns 205,789 shares of the biopharmaceutical company’s stock worth $13,117,000 after purchasing an additional 16,310 shares in the last quarter. Finally, First Interstate Bank lifted its stake in Bristol-Myers Squibb by 6.3% in the 3rd quarter. First Interstate Bank now owns 118,681 shares of the biopharmaceutical company’s stock worth $7,565,000 after purchasing an additional 7,030 shares in the last quarter. Institutional investors own 71.51% of the company’s stock.

How to Become a New Pot Stock Millionaire

Bristol-Myers Squibb stock opened at $60.88 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.43 and a current ratio of 1.55. The firm has a market cap of $99,391.66, a PE ratio of 20.23, a P/E/G ratio of 1.58 and a beta of 0.96. Bristol-Myers Squibb has a fifty-two week low of $51.56 and a fifty-two week high of $70.05.

Bristol-Myers Squibb (NYSE:BMY) last posted its quarterly earnings data on Monday, February 5th. The biopharmaceutical company reported $0.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.67 by $0.01. Bristol-Myers Squibb had a net margin of 4.85% and a return on equity of 35.43%. The firm had revenue of $5.45 billion for the quarter, compared to analysts’ expectations of $5.35 billion. During the same quarter last year, the company posted $0.63 EPS. The business’s quarterly revenue was up 3.9% on a year-over-year basis. equities analysts forecast that Bristol-Myers Squibb will post 3.22 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 1st. Investors of record on Friday, April 6th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.63%. The ex-dividend date is Thursday, April 5th. Bristol-Myers Squibb’s dividend payout ratio is currently 53.16%.

Several research firms have issued reports on BMY. Jefferies Group set a $70.00 target price on shares of Bristol-Myers Squibb and gave the stock a “hold” rating in a research note on Friday, March 23rd. ValuEngine cut shares of Bristol-Myers Squibb from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Vetr upgraded shares of Bristol-Myers Squibb from a “sell” rating to a “hold” rating and set a $60.72 target price on the stock in a research note on Thursday, February 1st. Argus reiterated a “buy” rating and issued a $66.43 target price (down from $75.00) on shares of Bristol-Myers Squibb in a research note on Wednesday, March 21st. Finally, Credit Suisse Group set a $62.00 target price on shares of Bristol-Myers Squibb and gave the stock a “hold” rating in a research note on Monday, January 22nd. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $66.68.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3340734/teachers-retirement-system-of-the-state-of-kentucky-sells-40083-shares-of-bristol-myers-squibb-bmy.html.

Bristol-Myers Squibb Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers drugs in the various therapeutic classes, such as oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus (HIV) infection.

Institutional Ownership by Quarter for Bristol-Myers Squibb (NYSE:BMY)

Receive News & Ratings for Bristol-Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol-Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Baker Hughes, a GE  Given a $34.00 Price Target at Jefferies Group
Baker Hughes, a GE Given a $34.00 Price Target at Jefferies Group
PFSweb  Upgraded to C by TheStreet
PFSweb Upgraded to C by TheStreet
Macquarie Infrastructure  Given a $45.00 Price Target by SunTrust Banks Analysts
Macquarie Infrastructure Given a $45.00 Price Target by SunTrust Banks Analysts
Alphabet  and The Competition Critical Comparison
Alphabet and The Competition Critical Comparison
Comparing Angle Energy  and Crusader Energy Group
Comparing Angle Energy and Crusader Energy Group
Brokerages Set Marriott International  Price Target at $128.50
Brokerages Set Marriott International Price Target at $128.50


© 2006-2018 Ticker Report. Google+.